AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases. Its mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function, enabling patients with these disorders to live fuller and healthier lives. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of AgomAb Therapeutics NV - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. AgomAb Therapeutics NV - ADR market cap is $366,200.00.
What is the 52-week high for AgomAb Therapeutics NV - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. AgomAb Therapeutics NV - ADR 52 week high is $16.00 as of February 10, 2026.
What is the 52-week low for AgomAb Therapeutics NV - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. AgomAb Therapeutics NV - ADR 52 week low is $12.66 as of February 10, 2026.
What is AgomAb Therapeutics NV - ADR stock price today?
AgomAb Therapeutics NV - ADR stock price today is $15.61.
What was AgomAb Therapeutics NV - ADR stock price yesterday?
AgomAb Therapeutics NV - ADR stock price yesterday was $14.65.
What is the Price-to-Book ratio of AgomAb Therapeutics NV - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. AgomAb Therapeutics NV - ADR P/B ratio is 0.0019.
What is the 50-day moving average of AgomAb Therapeutics NV - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. AgomAb Therapeutics NV - ADR 50-day moving average is $15.33.